“We Can’t Do It All Alone” Pfizer UK Tells Life Sciences Meeting
Executive Summary
Incoming Pfizer UK country manager Ben Osborn outlined the delivery challenges ahead for health-care systems globally at the BioWales Showcase, in London in late February.
You may also be interested in...
Killer Cures: Industry Heavyweights Make Their Presence Felt In Cell And Gene Therapy
Cell and gene therapies, described as the most exciting developments in the life sciences industry, pick up more momentum with every passing month. The spiraling enthusiasm for an activity that will change how health care is delivered was captured by GE, GSK and other key industry players at a leading UK life sciences industry meeting in spring 2017.
BioWales 2009: Size does matter
£1.3bn ($1.84bn) is the figure quoted most frequently in answer to the question: What is the value of the bioscience industry in Wales? But that figure is a year old, and undersells a dynamic and growing sector. So says MediWales forum manager Gwyn Tudor.
UK Life Sciences Cautiously Upbeat For Investment Year Ahead – BioWales 2024
Favorable UK biopharma investment trends have been reported by the BioIndustry Association, but can medtech and healthtech share in the positivity? A roundtable at the BioWales in London 2024 event framed the outlook for non-pharma players.